Advertisement

The Respiratory, Renal, and Hepatic Systems: Effects of Cardiac Surgery and Cardiopulmonary Bypass

  • James G. Ramsay

Abstract

The pathophysiology of cardiopulmonary bypass (CPB), as described in the preceding chapters, includes hemodilution (both red cells and plasma proteins), fluid accumulation, hypothermia, and the response of blood components to artificial surfaces. Superimposed on these processes are the mechanical complications inherent in cardiac surgery, and the consequences of inadequate organ perfusion secondary to myocardial failure in the perioperative period. Particularly in the respiratory system, it is often difficult to ascribe changes in function to any one of these aspects of the procedure. This section of the chapter delineates the effects of cardiac surgery and CPB on the individual components of the respiratory system. Additionally, the “postperfusion lung” and possible causes for this syndrome are described and potential prophylactic therapies discussed.

Keywords

Cardiopulmonary Bypass Renal Blood Flow Adult Respiratory Distress Syndrome Extravascular Lung Water Colloid Osmotic Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Baer DM, Osborn JJ. The postperfusion pulmonary congestion syndrome. Am J Clin Pathol 1960; 34: 442–445.PubMedGoogle Scholar
  2. 2.
    Peters RM, Wellons HA, Howe TM. Total compliance and work of breathing after thoracotomy. J Thorac Cardiovasc Surg 1969; 57: 348–355.PubMedGoogle Scholar
  3. 3.
    Vargas FS, Cukier A, Terra-Filho M, et al. Relationship between pleural changes after myocardial revascularization and pulmonary mechanics. Chest 1992; 102: 1333–1336.PubMedGoogle Scholar
  4. 4.
    Zin WA, Caldiera MPR, Cardoso WV, et al. Expiratory mechanics before and after uncomplicated cardiac surgery. Chest 1989; 95: 21–28.PubMedGoogle Scholar
  5. 5.
    Casey WF, Wynands JE, Ralley FE, et al. The role of intrathecal morphine in the anesthetic management of patients undergoing coronary artery bypass grafting. J Cardiothorac Anesth 1987; 1: 510–516.PubMedGoogle Scholar
  6. 6.
    Braun SR, Birnbaum ML, Chopra PS. Pre-and postoperative pulmonary function abnormalities in coronary artery revascularization surgery. Chest 1978; 73: 316–320.PubMedGoogle Scholar
  7. 7.
    Berrizbeitia LD, Tessler S, Jacobowitz IJ, et al. Effect of sternotomy and coronary bypass surgery on postoperative pulmonary mechanics. Chest 1989; 96: 873–876.PubMedGoogle Scholar
  8. 8.
    Stock MC, Downs JB, Weaver D, et al. Effect of pleurotomy on pulmonary function after median sternotomy. Ann Thorac Surg 1986; 42: 441–444.PubMedGoogle Scholar
  9. 9.
    Simmoneau G, Viven A, Sartene R, et al. Diaphragm dysfunction induced by upper abdominal surgery. Am Rev Resp Dis 1983; 128: 899–903.Google Scholar
  10. 10.
    Mankikian B, Cantinea U, Bertrand M, et al. Improvement of diaphragmatic function by a thoracic extradural block after upper abdominal surgery. Anesthesiology 1988; 68: 379–386.Google Scholar
  11. 11.
    Estenne M, Yernault JC, De Smet JM, et al. Phrenic and diaphragm function after coronary artery bypass grafting. Thorax 1985; 40: 293–299.PubMedGoogle Scholar
  12. 12.
    Locke TJ, Griffiths TL, Mould H, et al. Rib cage mechanics after median sternotomy. Thorax 1990; 45: 465–468.PubMedGoogle Scholar
  13. 13.
    Wilson RS, Sullivan SF, Malm JR, et al. The oxygen cost of breathing following anesthesia and cardiac surgery. Anesthesiology 1973; 39: 387–393.PubMedGoogle Scholar
  14. 14.
    Field S, Kelly SM, Macklem PT. The oxygen cost of breathing in patients with cardiopulmonary disease. Am Rev Resp Dis 1982; 126: 9–13.PubMedGoogle Scholar
  15. 15.
    Scandell JG, Shaw RS, Burke JF, et al. Operative treatment of aortic stenosis in the adult. Circulation 1963; 27: 772–778.Google Scholar
  16. 16.
    Esposito RA, Spencer FC. The effect of pericardial insulation on hypothermic phrenic nerve injury during open heart surgery. Ann Thorac Surg 1987; 43: 303–308.PubMedGoogle Scholar
  17. 17.
    Wilcox P, Baffle EM, Hards J, et al. Phrenic nerve function and its relationship to atelectasis after coronary artery bypass surgery. Chest 1988; 93: 693–698.PubMedGoogle Scholar
  18. 18.
    Fedullo AJ, Lerner RM, Gibson J, et al. Sonographic measurement of diaphragmatic motion after coronary artery bypass surgery. Chest 1992; 102: 1683–1686.PubMedGoogle Scholar
  19. 19.
    Diehl JL, Lofaso F, Deleuze P, et al. Clinically relevant diaphragmatic dysfunction after cardiac operations. J Thorac Cardiovasc Surg 1994; 107: 487–498.PubMedGoogle Scholar
  20. 20.
    Panossian A, Hagstrom JWC, Nehlsen SL, et al. Secondary nature of surfactant changes in postperfusion pulmonary damage. J Thorac Cardiovasc Surg 1969; 57: 628–634.PubMedGoogle Scholar
  21. 21.
    Phang PT, Keough KMW. Inhibition of pulmonary surfactant by plasma from normal adults and from patients having cardiopulmonary bypass. J Thorac Cardiovasc Surg 1986; 91: 248–251.PubMedGoogle Scholar
  22. 22.
    Rea HH, Harris EA, Seelye ER, et al. The effects of cardiopulmonary bypass upon pulmonary gas exchange. J Thorac Cardiovasc Surg 1978; 75: 104–120.PubMedGoogle Scholar
  23. 23.
    Dantzker DR, Cowenhaven WM, Willoughby WJ, et al. Gas exchange alterations associated with weaning from mechanical ventilation following coronary artery bypass grafting. Chest 1982; 82: 674–677.PubMedGoogle Scholar
  24. 24.
    Singh NP, Vargas FS, Cukier A, et al. Arterial blood gases after coronary artery bypass surgery. Chest 1992; 102: 1337–1341.Google Scholar
  25. 25.
    Staub NC. Pulmonary edema. Physiol Rev 1974; 54: 678.PubMedGoogle Scholar
  26. 26.
    Zarins CZ, Rice CL, Peters RM, et al. Lymph and pulmonary response to isobaric reduction in plasma oncotic pressure in baboons. Circ Res 1978; 43: 925–930.PubMedGoogle Scholar
  27. 27.
    Pearl RG, Halperin BD, Mihm F, et al. Pulmonary effects of crystalloid and colloid resuscitation from hemorrhagic shock in the presence of oleic acid-induced pulmonary capillary injury in the dog. Anesthesiology 1988; 68: 12–20.PubMedGoogle Scholar
  28. 28.
    Gallagher J, Banner MJ, Barnes PA. Large volume crystalloid resuscitation does not increase extravascular lung water. Anesth Analg 1985; 64: 323–326.PubMedGoogle Scholar
  29. 29.
    Louagie Y, Gonzalez E, Jamart J, et al. Postcardiopulmonary bypass lung edema: a preventable complication? Chest 1993; 103: 86–95.PubMedGoogle Scholar
  30. 30.
    Braude S, Nolop KB, Fleming JS, et al. Increased pulmonary transvascular protein flux after canine cardiopulmonary bypass: association with lung neutrophil sequestration and tissue peroxidation. Am Rev Resp Dis 1986; 134: 867–872.PubMedGoogle Scholar
  31. 31.
    Smith EEJ, Naftel DC, Blackstone EH, et al. Microvascular permeability after cardiopulmonary bypass; an experimental study. J Thorac Cardiovasc Surg 1987; 94: 225–233.PubMedGoogle Scholar
  32. 32.
    Royston D, Minty BD, Biol MI, et al. The effect of surgery with cardiopulmonary bypass on alveolar-capillary barrier function in human beings. Ann Thorac Surg 1985; 40: 139143.Google Scholar
  33. 33.
    Raijmakers PGHM, Groeneveld ABJ, Schneider AJ, et al. Transvascular transport of 67Ga in the lungs after cardiopulmonary bypass surgery. Chest 1993; 104: 1825–1832.PubMedGoogle Scholar
  34. 34.
    Tennenberg SD, Clardy DCW, Bailey WW, et al. Complement activation and lung permeability during cardiopulmonary bypass. Ann Thorac Surg 1990; 50: 597–601.PubMedGoogle Scholar
  35. 35.
    Byrick RJ, Kay JC, Noble WH. Extravascular lung water accumulation in patients following coronary artery surgery. Can Anaesth Soc J 1977; 24: 332–345.PubMedGoogle Scholar
  36. 36.
    Boldt J, Bormann BV, Kling D, et al. The influence of extracorporeal circulation on extravascular lung water in coronary surgery patients. Thorac Cardiovasc Surg 1986; 34: 111–115.Google Scholar
  37. 37.
    Boldt J, Kling D, von Bormann B, et al. Reanimation and extravaskulares lungenwasser in der herzchirurgie. Anesthetist 1988; 37: 91–96.Google Scholar
  38. 38.
    Gallagher JD, Moore RA, Kerns D. Effects of colloid or crystalloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting. Anesth Analg 1985; 64: 753–758.PubMedGoogle Scholar
  39. 39.
    Sivak ED, Starr NJ, Graves JW, et al. Extravascular lung water values in patients undergoing coronary artery bypass surgery. Crit Care Med 1982; 10: 593–596.PubMedGoogle Scholar
  40. 40.
    Brigham KL, Faulkner SL, Fisher D, et al. Lung water and urea indicator dilution studies in cardiac surgery patients. Circulation 1976; 53: 369–376.PubMedGoogle Scholar
  41. 41.
    Klancke KA, Assey ME, Kratz JM, et al. Postoperative pulmonary edema in postcoronary artery bypass graft patients. Chest 1983; 84: 529–534.Google Scholar
  42. 42.
    Yeh, T, Parmar JM, Rebeyka IM, et al. Limiting edema in neonatal cardiopulmonary bypass with narrow-range molecular weight hydroxyethyl starch. J Thorac Cardiovasc Surg 1992; 104: 659–665.PubMedGoogle Scholar
  43. 43.
    Marelli D, Samson R, Edgell D, et al. Does the addition of albumin to the prime solution in cardiopulmonary bypass affect clinical outcome? J Thorac Cardiovasc Surg 1989; 98: 751–756.PubMedGoogle Scholar
  44. 44.
    Hallowell P, Bland JHL, Dalton BC, et al. The effect of hemodilution with albumin or ringer’s lactate on water balance and blood use in open-heart surgery. Ann Thorac Surg 1978; 25: 22–29.PubMedGoogle Scholar
  45. 45.
    Byrick RJ, Noble WH. Postperfusion lung syndrome: comparison of travenol bubble and membrane oxygenators. J Thorac Cardiovasc Surg 1978; 76: 685–693.PubMedGoogle Scholar
  46. 46.
    Gould FK, Freeman R, Brown MA. Respiratory complications following cardiac surgery; the role of microbiology in its evaluation. Anaesthesia 1985; 40: 1061–1064.PubMedGoogle Scholar
  47. 47.
    Weiss ME, Nyhan D, Zhikang P, et al. Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine. N Engl J Med 1989; 320: 886–892.PubMedGoogle Scholar
  48. 48.
    Latson TW, Kickler TS, Baumgartener WA. Pulmonary hypertension and noncardiogenic pulmonary edema following cardiopulmonary bypass associated with an anti-granulocyte antibody. Anesthesiology 1986; 64: 106–111.PubMedGoogle Scholar
  49. 49.
    Dodrill FD. The effects of total body perfusion upon the lungs. In: Allen JG, ed. Extracorporeal Circulation. Springfield, IL: Charles C Tomas; 1960: 327–335.Google Scholar
  50. 50.
    Anyanwu E, Dittrich H, Gieseking R, et al. Ultrastructural changes in the human lung following cardiopulmonary bypass. Bas Res Cardiol 1982; 77: 309–332.Google Scholar
  51. 51.
    Asada S, Yamaguchi M. Fine structural change in the lung following cardiopulmonary bypass; its relation to early postoperative course. Chest 1971; 59: 478–483.PubMedGoogle Scholar
  52. 52.
    Ratliff NB, Young GW, Hackel DB, et al. Pulmonary injury secondary to extracorporeal circulation. J Thorac Cardiovasc Surg 1973; 65: 425–432.PubMedGoogle Scholar
  53. 53.
    Neville WE, Kontaxis A, Gavin T, et al. Postperfusion pulmonary vasculitis. Arch Surg 1963; 86: 126–137.Google Scholar
  54. 54.
    Hyers TM. Adult respiratory distress syndrome: definition, risk factors, and outcome. In: Zapol WM, Lemaire F, eds. Adult Respiratory Distress Syndrome. New York: Marcel Dekker Inc; 1991: 23–36.Google Scholar
  55. 55.
    Fein AM, Goldbery SK, Lippman ML, et al. Adult respiratory distress syndrome. Br JAnaesth 1982; 54: 723–729.Google Scholar
  56. 56.
    Fowler AA, Hamman RF, Good JT, et al. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med 1983; 98: 593–597.PubMedGoogle Scholar
  57. 57.
    Zapol WM, Frikker MJ, Pontoppidan H, et al. The adult respiratory distress syndrome at Massachusetts General Hospital: etiology, progression, and survival rates 1978–1988. In: Zapol WM, Lemaire F, eds. Adult Respiratory Distress Syndrome. New York: Marcel Dekker Inc; 1991: 367–380.Google Scholar
  58. 58.
    Messent M, Sullivan K, Keogh BF, et al. Adult respiratory distress syndrome following cardiopulmonary bypass: incidence and prediction. Anesthesia 1992; 47: 267–268.Google Scholar
  59. 59.
    Maunder RJ, Hudson LD. Clinical risks associated with the adult respiratory distress syndrome. In: Zapol WM, Lemaire F, eds. Adult Respiratory Distress Syndrome. New York: Marcel Dekker Inc; 1991: 1–21.Google Scholar
  60. 60.
    Haynes BF, Fauci AS. Introduction to clinical immunology. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al, eds. Harrison’s Principles of Internal Medicine. 11th ed. New York: McGraw-Hill; 1987: 328–337.Google Scholar
  61. 61.
    Jacob HS. Complement-mediated leucoembolization: a mechanism of tissue damage during extracorporeal perfusions, myocardial infarction, and shock-a review. Q J Med 1983; 52: 289–296.PubMedGoogle Scholar
  62. 62.
    Knudsen F, Andersen LW. Immunological aspects of cardiopulmonary bypass. J Cardiothorac Anesth 1990; 4: 245258.Google Scholar
  63. 63.
    Craddock PR, Fehr J, Brigham KL, et al. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 1977; 296: 769–774.PubMedGoogle Scholar
  64. 64.
    Hammerschmidt DE, Craddock PR, McCullough J, et al. Complement activation and pulmonary leukostasis during nylon fiber filtration leukapheresis. Blood 1978; 51: 72 1730.Google Scholar
  65. 65.
    Chenowith DE, Cooper SW, Hugh TE, et al. Complement activation during cardiopulmonary bypass, evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304: 497–503.Google Scholar
  66. 66.
    Tamiya T, Yamasaki M, Maeo Y, et al. Complement activation in cardiopulmonary bypass, with special reference to anaphylatoxin production in membrane and bubble oxygenators. Ann Thorac Surg 1988; 46: 47–57.PubMedGoogle Scholar
  67. 67.
    Cavarocchi NC, Pluth JR, Schaff HV, et al. Complement activation during cardiopulmonary bypass: comparison of bubble and membrane oxygenators. J Thorac Cardiovasc Surg 1986; 91: 252–258.PubMedGoogle Scholar
  68. 68.
    van Oeveren W, Kazatchkine MD, Descaps-Latscha B, et al. Deleterious effects of cardiopulmonary bypass: a prospective study of bubble versus membrane oxygenation. J Thorac Cardiovasc Surg 1985; 89: 888–899.PubMedGoogle Scholar
  69. 69.
    Riegel W, Spillner G, Schlosser V, et al. Plasma levels of main granulocyte components during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1988; 95: 1014–1019.Google Scholar
  70. 70.
    Howard RJ, Crain C, Franzini DA, et al. Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation. Arch Surg 1988; 123: 1496–1501.PubMedGoogle Scholar
  71. 71.
    Videm V, Fosse E, Mollnes TE, Carred P, et al. Time for new concepts about measurement of complement activation by cardiopulmonary bypass? Ann Thorac Surg 1992; 54: 725–731.PubMedGoogle Scholar
  72. 72.
    Kirklin JK, Westaby S, Blackstone EH, et al. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845–857.PubMedGoogle Scholar
  73. 73.
    Salama A, Hugo F, Heinrich D, et al. Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass. N Engl J Med 1988; 318: 408–414.PubMedGoogle Scholar
  74. 74.
    Mollnes TE, Videm V, Gotze O, et al. Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin. Ann Thorac Surg 1991; 52: 92–97.PubMedGoogle Scholar
  75. 75.
    Andersen LW, Baek L, Degn H, et al. Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg 1987; 93: 115–119.PubMedGoogle Scholar
  76. 76.
    Rocke DA, Gaffin SL, Wells MT, et al. Endotoxinemia associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1987; 93: 832–837.PubMedGoogle Scholar
  77. 77.
    Andersen LW, Jensen TH, Jensen FM, et al. Absorption of lipopolysaccharide from the intestine during aortic cross-clamping in humans J Cardiothorac Anesth 1988; 2: 861–863.PubMedGoogle Scholar
  78. 78.
    Anderson BO, Brown JM, Bensard DD, et al. Reversible lung neutrophil accumulation can cause injury by elastasemediated mechanisms. Surgery 1990; 108: 262–268.PubMedGoogle Scholar
  79. 79.
    Worthen GS, Haslett C, Rees AJ, et al. Neutrophilmediated pulmonary vascular injury. Am Rev Resp Dis 1987; 136: 19–28.PubMedGoogle Scholar
  80. 80.
    Royston D, Fleming JS, Desai JB, et al. Increased production of peroxidation products associated with cardiac operations. J Thorac Cardiovasc Surg 1986; 91: 759–766.PubMedGoogle Scholar
  81. 81.
    Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365–376.PubMedGoogle Scholar
  82. 82.
    Weiland JE, Davis B, Holter JF, et al. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiological significances. Am Rev Resp Dis 1986; 133: 218–225.PubMedGoogle Scholar
  83. 83.
    Faymonville ME, Pincemail J, Duchateau J, et al. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg 1991; 102: 309–317.PubMedGoogle Scholar
  84. 84.
    Wachtfogel YT, Kucich U, Greenplate J, et al Human neutrophil degranulation during extracorporeal circulation. Blood 1987; 69: 324–330.PubMedGoogle Scholar
  85. 85.
    Colman RW. Platelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg 1990; 49: 32–34.PubMedGoogle Scholar
  86. 86.
    Stahl RF, Fisher CA, Kucich U, et al. Effects of simulated extracorporeal circulation on human leukocyte elastase release, superoxide generation, and procoagulant activity. J Thorac Cardiovasc Surg 1991; 101: 230–239.PubMedGoogle Scholar
  87. 87.
    Andersen LW, Baek L, Thomsen BS, et al. Effect of methylprednisolone on endotoxemia and complement activation during cardiac surgery. J Cardiothorac Anesth 1989; 3: 544–549.PubMedGoogle Scholar
  88. 88.
    Hart DHL. Polymorphonuclear leukocyte elastase activity is increased by bacterial lipopolysaccharide; a response inhibited by glucocorticoids. Blood 1984; 63: 421–426.PubMedGoogle Scholar
  89. 89.
    Bonser M, Dave JR, Davies ET, et al. Reduction of complement activation during bypass by prime manipulation. Ann Thorac Surg 1990; 49: 279–283.PubMedGoogle Scholar
  90. 90.
    Videm V, Nillson L, Venge P, et al. Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. Artif Organs 1991; 15: 90–95.PubMedGoogle Scholar
  91. 91.
    Boroweic J, Thelin S, Bagge L, et al. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992; 104: 642–647.Google Scholar
  92. 92.
    Menasche P, Pasquier C, Bellucci S, et al. Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man. J Thorac Cardiovasc Surg 1988; 96: 582–589.PubMedGoogle Scholar
  93. 93.
    Kuratani T, Matsuda H, Sawa Y, et al. Experimental study in a rabbit model of ischemia-reperfusion lung injury during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992; 103: 564–568.PubMedGoogle Scholar
  94. 94.
    Bando K, Pillai R, Cameron DE, et al. Leukocyte depletion ameliorates free-radical mediated lung injury following cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 99: 873–877.PubMedGoogle Scholar
  95. 95.
    Higgins TL, Yared JP, Paranandi L, et al. Risk factors for respiratory complications after cardiac surgery. Anesthesiology 1991;75:A258. Abstract.Google Scholar
  96. 96.
    Huddy SPJ, Joyce WP, Pepper JR. Gastrointestinal complications in 4473 patients who underwent cardiopulmonary bypass surgery. Br J Surg 1991; 78: 293–296.PubMedGoogle Scholar
  97. 97.
    Heikkinen LO, Ala-Kulju KV. Abdominal complications following cardiopulmonary bypass in open-heart surgery. Scand J Thorac Cardiovasc Surg 1987;21:1–7.PubMedGoogle Scholar
  98. 98.
    Pinson CW, Alberty RE. General surgical complications after cardiopulmonary bypass surgery. Am J Surg 1983; 146: 133–137.PubMedGoogle Scholar
  99. 99.
    Wallwork J, Davidson KG. The acute abdomen following cardiopulmonary bypass surgery. Br J Surg 1980; 67: 410–412.PubMedGoogle Scholar
  100. 100.
    Hanks JB, Curtis SE, Hanks BB, et al. Gastrointestinal complications after cardiopulmonary bypass. Surgery 1982; 92: 394–400.PubMedGoogle Scholar
  101. 101.
    Welling RE, Rath R, Albers JE, et al. Gastrointestinal complications after cardiac surgery. Arch Surg 1986; 121: 1178–1180.PubMedGoogle Scholar
  102. 102.
    Leitman IM, Paull DE, Barie PS, et al. Intraabdominal complications of cardiopulmonary bypass operations. Surg Gynecol Obstet 1987; 165: 251–254.PubMedGoogle Scholar
  103. 103.
    Moneta GL, Misback GA, Ivey TD. Hypoperfusion as a possible factor in the development of gastrointestinal complications after cardiac surgery. Am J Surg 1985; 149: 648–650.PubMedGoogle Scholar
  104. 104.
    Collins JD, Bassendine MF, Ferner R, et al. Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet 1983; 1 (8334): 1119–1123.PubMedGoogle Scholar
  105. 105.
    Rattner DW, Gu Z-Y, Vlahakes GJ, et al. Hyperamylasemia after cardiac surgery. Ann Surg 1989; 209: 279–283.PubMedGoogle Scholar
  106. 106.
    Kazmierczak SC, Van Lente F. Incidence and source of hyperamylasemia after cardiac surgery. Clin Chem 1988; 34: 916–919.PubMedGoogle Scholar
  107. 107.
    Fiddian-Green RG, Baker S. The predictive value of measurements of pH in the wall of the stomach for complications after cardiac surgery: a comparison with other forms of monitoring. Crit Care Med 1987; 15: 153–156.PubMedGoogle Scholar
  108. 108.
    Andersen LW, Landow L, Baek L, et al. Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-a concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 1993; 21: 210–217.PubMedGoogle Scholar
  109. 109.
    Landow L, Phillips DA, Heard SO, et al. Gastric tonometry and venous oximetry in cardiac surgery patients. Crit Care Med 1991; 19: 1226–1233.PubMedGoogle Scholar
  110. 110.
    Karlstad MD, Patteson SK, Guszcza JA, et al. Methylprednisolone does not influence endotoxin translocation during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1993; 7: 23–27.PubMedGoogle Scholar
  111. 111.
    Hampton WW, Townsend MC, Schirmer WJ, et al. Effective hepatic blood flow during cardiopulmonary bypass. Arch Surg 1989; 124: 458–459.PubMedGoogle Scholar
  112. 112.
    Mori A, Watanabe K, Onoe M, et al. Regional blood flow in the liver, pancreas and kidney during pulsatile and non-pulsatile perfusion under profound hypothermia. Jpn Circ J 1988; 52: 219–227.PubMedGoogle Scholar
  113. 113.
    Taylor KM, Bain WH, Morton JJ. The role of angiotensin II in the development of peripheral vasoconstriction during open heart surgery. Am Heart J 1980; 100: 935–937.PubMedGoogle Scholar
  114. 114.
    Kumon K, Tanaka K, Hirata T, et al. Organ failures due to low cardiac output syndrome following open heart surgery. Jpn Circ J 1986;50:329–335.PubMedGoogle Scholar
  115. 115.
    Fernandez-del Castillo C, Harringer W, Warshaw AL, et al. Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med 1991; 325: 382–387.Google Scholar
  116. 116.
    Svensson LG, Decker G, Kinsley RB. A prospective study of hyperamylasemia and pancreatitis after cardiopulmonary bypass. Ann Thorac Surg 1985; 39: 409–411.PubMedGoogle Scholar
  117. 117.
    Reber HA. Acute pancreatitis-another piece of the puzzle? N Engl J Med 1991; 325: 423–425.PubMedGoogle Scholar
  118. 118.
    Murray WR, Mittra S, Mittra D, et al. The amylasecreatinine clearance ratio following cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981; 82: 248–253.PubMedGoogle Scholar
  119. 119.
    Aziz S, Bergdahl L, Baldwin JC, et al. Pancreatitis after cardiac and cardiopulmonary transplantation. Surgery 1985; 97: 653–661.PubMedGoogle Scholar
  120. 120.
    Steed DL, Brown B, Reilly JJ, et al. General surgical complications in heart and heart-lung transplantations. Surgery 1985; 98: 739–745.PubMedGoogle Scholar
  121. 121.
    Porter GA, Kloster FE, Herr RJ, et al. Renal complications associated with valve replacement surgery. J Thorac Cardiovasc Surg 1967; 53: 145–152.PubMedGoogle Scholar
  122. 122.
    Bhat JG, Gluck MC, Lowenstein J, et al. Renal failure after open heart surgery. Ann Intern Med 1976; 84: 677–682.PubMedGoogle Scholar
  123. 123.
    Lange HW, Aeppli DM, Brown DC. Survival of patients with acute renal failure requiring dialysis after open heart surgery: early prognostic indicators. Am Heart J 1987; 113: 1138–1143.PubMedGoogle Scholar
  124. 124.
    Porter GA, Kloster FE, Herr RJ, et al. Relationship between alterations in renal hemodynamics during cardiopulmonary bypass and postoperative renal function. Circulation 1966; 34: 1005–1021.PubMedGoogle Scholar
  125. 125.
    Grismer JT, Levy MJ, Lillehei RC, et al. Renal function in acquired valvular heart disease and effects of extracorporeal circulation. Surgery 1964; 55: 24–41.PubMedGoogle Scholar
  126. 126.
    Lundberg S. Renal function during anaesthesia and open-heart surgery in man. Acta Anaesth Scand (Suppl) 1967; 27: 1–82.Google Scholar
  127. 127.
    Finsterbusch W, Long DM, Sellers RD, et al. Renal arteriography during extracorporeal circulation in dogs, with a preliminary report upon the effects of low molecular weight dextran. J Thorac Cardiovasc Surg 1961; 41: 252–262.PubMedGoogle Scholar
  128. 128.
    Moghissi K, MacLell ES, Munday KA. Changes in renal blood flow and PAH extraction during extracorporeal circulation of short and long duration. Cardiovasc Res 1969; 3: 37–44.PubMedGoogle Scholar
  129. 129.
    German JC, Chalmers GS, Hirai J, et al. Comparison of nonpulsatile and pulsatile extracorporeal circulation on renal tissue perfusion. Chest 1972; 61: 65–69.PubMedGoogle Scholar
  130. 130.
    Philbin DM, Levine FH, Kono K, et al. Attenuation of the stress response to cardiopulmonary bypass by the addition of pulsatile flow. Circulation 1981; 64: 808–812.PubMedGoogle Scholar
  131. 131.
    Watkins L Jr, Lucas SK, Gardner TJ, et al. Angiotensin II levels during cardiopulmonary bypass; a comparison of pulsatile and nonpulsatile flow. Surg Forum 1979; 30: 229–235.PubMedGoogle Scholar
  132. 132.
    Hickey PR, Buckley MJ, Philbin DM. Pulsatile and non-pulsatile cardiopulmonary bypass: review of a counterproductive controversy. Ann Thorac Surg 1983; 36: 720–737.PubMedGoogle Scholar
  133. 133.
    Yeboah ED, Petrie A, Pead JL. Acute renal failure and open heart surgery. Br Med J 1972; 1: 415–418.PubMedGoogle Scholar
  134. 134.
    Yeh TJ, Brackney EL, Hall, et al. Renal complications of open-heart surgery: predisposing factors, prevention, and management. J Thorac Cardiovasc Surg 1964; 47: 79–97.PubMedGoogle Scholar
  135. 135.
    Hilberman M, Myers BD, Carrie BJ, et al. Acute renal failure following cardiac surgery. J Thorac Cardiovasc Surg 1979; 77: 880–888.PubMedGoogle Scholar
  136. 136.
    Abel RM, Buckley MJ, Austen WG, et al. Etiology, incidence, and prognosis of renal failure following cardiac operations: results of a prospective analysis of 500 consecutive patients. J Thorac Cardiovasc Surg 1976; 71: 323–333.PubMedGoogle Scholar
  137. 137.
    McLeish KR, Loft FC, Kleit SA. Factors affecting prognosis in acute renal failure following cardiac operations. Surg Gynecol Obstet 1977; 145: 28–32.PubMedGoogle Scholar
  138. 138.
    Koning HM, Koning AJ, Defauw JJ. Optimal perfusion during extra-corporeal circulation. Scand J Thorac Cardiovase Surg 1987; 21: 207–213.Google Scholar
  139. 139.
    Lowe MB. Effects of nephrotoxins on ischemia in experimental hemoglobinuria. J Pathol Bacteriol 1966; 92: 319–323.PubMedGoogle Scholar
  140. 140.
    Krian A. Incidence, prevention, and treatment of acute renal failure following cardiopulmonary bypass. Int Anesthesiol Clin 1976; 14: 87–101.PubMedGoogle Scholar
  141. 141.
    Hilberman L, Derby GC, Spencer RJ, et al. Sequential pathophysiological changes characterizing the progression from renal dysfunction to acute renal failure following cardiac operations. J Thorac Cardiovasc Surg 1980;79:838–844.PubMedGoogle Scholar
  142. 142.
    Bourgeois BFD, Donath A, Paunier C, et al. Effects of cardiac surgery on renal function in children. J Thorac Cardiovasc Surg 1979; 77: 283–286.PubMedGoogle Scholar
  143. 143.
    Mazzarella V, Gallucci MT, Tozzo C, et al. Renal function in patients undergoing cardiopulmonary bypass operations. J Thorac Cardiovasc Surg 1992; 104: 1625–1627.PubMedGoogle Scholar
  144. 144.
    Myers BD, Moran MS. Hemodynamically mediated acute renal failure. N Engl J Med 1986; 314: 97–105.PubMedGoogle Scholar
  145. 145.
    Doberneck RC, Reiser MP, Lillehei CW. Acute renal failure after open-heart surgery utilizing extracorporeal circulation and total body perfusion. J Thorac Cardiovasc Surg 1962; 43: 441–452.PubMedGoogle Scholar
  146. 146.
    Corwin HL, Sprague SM, DeLaria GA, et al. Acute renal failure associated with cardiac operations; a case control study. J Thorac Cardiovasc Surg 1989; 98: 1107–1112.PubMedGoogle Scholar
  147. 147.
    Gailiunas P Jr, Chalwa R, Lazarus JM, et al. Acute renal failure following cardiac operations. J Thorac Cardiovasc Surg 1980; 79: 241–243.PubMedGoogle Scholar
  148. 148.
    Johnson PA, Bernard DB, Donohoe JF, et al. Effect of volume expansion on hemodynamics of the hypoperfused rat kidney. J Clin Invest 1979; 64: 550–558.Google Scholar
  149. 149.
    Burke TJ, Cronin RE, Duchin KL, et al. Ischemia and tubule obstruction during acute renal failure in dogs; mannitol in protection. Am J Physiol 1980; 238: F305–314.PubMedGoogle Scholar
  150. 150.
    Schuster SR, Kakvan M, Vawter GF, et al. An experimental study of the effect of mannitol during cardiopulmonary bypass. Circulation 1964; 29 (suppl): 72–76.PubMedGoogle Scholar
  151. 151.
    Kahn DR, Cerny JC, Lee RWS, et al. The effect of dextran and mannitol on renal function during open heart surgery. Surgery 1965; 57: 676–679.PubMedGoogle Scholar
  152. 152.
    Hanley MJ, Davidson K. Prior mannitol and furosemide infusion in a model of ischemic acute renal failure. Am J Physiol 1981; 241: F556–564.PubMedGoogle Scholar
  153. 153.
    Engelman RM, Gouge TH, Smith SJ, et al. The effect of diuretics on renal hemodynamics during cardiopulmonary bypass. J Surg Res 1974; 16: 268–275.PubMedGoogle Scholar
  154. 154.
    Kron IL, Jodb AW, Van Meter C. Acute renal failure in the cardiovascular surgical patient (current review). Ann Thorac Surg 1985; 39: 590–598.PubMedGoogle Scholar
  155. 155.
    Weinberger HD, Anderson RJ. Prevention of acute renal failure. J Crit Care 1991; 6: 95–101.Google Scholar
  156. 156.
    Leuers PB, Mulder AW, Fiers HA, et al. Acute renal failure after cardiovascular surgery. Current concepts in pathophysiology, prevention, and treatment. Eur Heart J 1989; 10 (suppl H): 38–42.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1995

Authors and Affiliations

  • James G. Ramsay

There are no affiliations available

Personalised recommendations